Abstract
A series of novel, MMP-1 sparing arylhydroxamate sulfonamides with activity against MMP-2 and -13 is described.
MeSH terms
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / pharmacology
-
Collagenases / chemistry
-
Collagenases / metabolism
-
Crystallography, X-Ray
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / pharmacology
-
Humans
-
Hydroxamic Acids / chemical synthesis
-
Hydroxamic Acids / pharmacology*
-
Inhibitory Concentration 50
-
Matrix Metalloproteinase 1 / chemistry
-
Matrix Metalloproteinase 1 / metabolism
-
Matrix Metalloproteinase 13
-
Matrix Metalloproteinase 2 / chemistry
-
Matrix Metalloproteinase 2 / metabolism
-
Matrix Metalloproteinase Inhibitors*
-
Models, Molecular
-
Structure-Activity Relationship
Substances
-
Antineoplastic Agents
-
Enzyme Inhibitors
-
Hydroxamic Acids
-
Matrix Metalloproteinase Inhibitors
-
Collagenases
-
MMP13 protein, human
-
Matrix Metalloproteinase 13
-
Matrix Metalloproteinase 2
-
Matrix Metalloproteinase 1